Analyses / ARM
118% YoY rally faces valuation wall; AI tailwinds offset by stretched multiples and insider selling pressure.
A free account reveals ARM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
AGI CPU ecosystem expansion (Oracle deal), 22.5% revenue growth, 97.5% gross margins, fortress balance sheet (6.0x current ratio). AI/data-center licensing model scales without fab capex. Early-stage TAM expansion in edge/enterprise.
▼ Bear Case
P/E 397x, P/S 73x, EV/EBITDA 310x — among the most extreme multiples in semiconductors. Down 6.6% today. Insider selling outpace buying 66:49. Stock up 118% in 1y; reversion risk high if macro softens or AI hype normalizes. Royalty/licensing dependent on fabless partners' capex cycles.
Valuation
OVERVALUED — score 28/100
P/E 397x, P/S 73x, EV/EBITDA 310x are at multi-year extremes. Justified only if ARM sustains 20%+ EPS growth indefinitely. Historical semiconductor comps trade 15–25x earnings. ARM pricing in flawless execution; limited margin for disappointment.
Technical Levels
Support · $300.00 (Recent 1-day low; minor support) · $280.00 (Gap-fill zone; psychological support) · $250.00 (2024 breakout origin; key long-term support)
Resistance · $335.00 (Today's open; near-term resistance) · $358.00 (Today's intraday high; immediate resistance) · $385.00 (Pre-selloff support/resistance confluence) · $453.00 (52-week high; structural resistance)
Financial Health
Score 88/100. Fortress balance sheet. Zero leverage, >5x liquidity cushion. Tangible book value ~$6.47; P/B 19.4x implies market pricing in decades of growth. No financial distress risk; valuation risk is the primary concern.
Catalysts
| Next quarterly earnings | ~60–90 days | High. Guidance on AGI CPU adoption, royalty growth, & new partnerships will reset valuation. Miss likely triggers 15–25% pullback. |
| Oracle OCI integration progress & design win announcements | Next 6 months | Medium-High. Proof of ecosystem expansion & competitive displacement of x86 = de-risk story. |
| Macro data: CPI, jobs, Fed rate path | Ongoing | High. Rate-sensitive; if recession signals mount, ARM compressed multiples likely accelerate. |
| Insider transactions | Ongoing | Medium. Continued selling above $350+ would signal exec skepticism. |
Risk Flags
See ARM's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock ARM free →Recent News
- Why a Hot July CPI Print Could Hit This Semiconductor Chip HardYahoo
- ARM Stock Soars 118% in a Year: Is the Buying Opportunity Gone?Yahoo
- Weak Jobs, Good News: These 10 Rate-Sensitive Stocks Are Soaring TodayBenzinga
- SoftBank Reopens Talks for $10 Billion Loan Backed by OpenAI Stake After Adding Repayment Guarantee to Ease Banks' Valuation Concerns: ReportBenzinga
- Arm (ARM) Stock Looks Expensive Despite Fresh Agentic AI Demand NewsYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full ARM analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
ARM FAQ
Is ARM a buy right now?
Arm Holdings PLC's current read is a Growth / Valuation Compression setup with 62 confidence over a 3–6 months horizon. Valuation: OVERVALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is ARM overvalued?
OVERVALUED (valuation score 28/100). P/E 397x, P/S 73x, EV/EBITDA 310x are at multi-year extremes. Justified only if ARM sustains 20%+ EPS growth indefinitely. Historical semiconductor comps trade 15–25x earnings. ARM pricing in flawless execution; limited margin for disappointment.
What are the risks of buying ARM?
P/E 397x, P/S 73x, EV/EBITDA 310x — among the most extreme multiples in semiconductors. Down 6.6% today. Insider selling outpace buying 66:49. Stock up 118% in 1y; reversion risk high if macro softens or AI hype normalizes. Royalty/licensing dependent on fabless partners' capex cycles.